{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:07:19Z","timestamp":1772744839132,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf00873965","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T19:40:26Z","timestamp":1103917226000},"page":"235-241","source":"Crossref","is-referenced-by-count":17,"title":["Phase II study of deoxyspergualin in metastatic breast cancer"],"prefix":"10.1007","volume":"12","author":[{"given":"Kapil","family":"Dhingra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Theriault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Booser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frankie","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aman","family":"Buzdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Fraschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00873965_CR1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.7164\/antibiotics.34.1619","volume":"34","author":"T Takeuchi","year":"1981","unstructured":"Takeuchi T, Iinuma H, Kunimoto S, Masuda T, Ishizuka M, Takeuchi M, Hamada M, Naganawa H, Kondo S, Umezawa H: A new antitumor antibiotic spergualin: isolation and antitumor activity. J Antibiot 34:1619\u20131621, 1981","journal-title":"J Antibiot"},{"issue":"2","key":"BF00873965_CR2","first-page":"2633","volume":"11","author":"T Takeuchi","year":"1984","unstructured":"Takeuchi T: Spergualin, a novel antitumor antibiotic produced byBacillus laterosporus. Jpn J Cancer Chemother 11(2):2633\u20132639, 1984","journal-title":"Jpn J Cancer Chemother"},{"key":"BF00873965_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7164\/antibiotics.40.561","volume":"40","author":"K Nemoto","year":"1987","unstructured":"Nemoto K, Hayashi M, Abe F: Immunosuppressive activities of 15-deoxyspergualin in animals. J Antibiot 40:561\u2013562. 1987","journal-title":"J Antibiot"},{"key":"BF00873965_CR4","first-page":"240","volume":"XX","author":"DSJ Collier","year":"1988","unstructured":"Collier DSJ, Caine R, Thiru S, Kohno H, Levickis J: 15-Deoxyspergualin in experimental dog renal allografts. Transplant Proc XX:240\u2013241, 1988","journal-title":"Transplant Proc"},{"key":"BF00873965_CR5","first-page":"229","volume":"XX","author":"H Amemiya","year":"1988","unstructured":"Amemiya H, Suzuki S, Manabe H, Fukao K, Iwasaki Y, Dohi K, Isono K, Orita K, Yamanaka N: 15-Deoxy-spergualin as an immunosuppressive agent in dogs. Transplant Proc XX:229\u2013232, 1988","journal-title":"Transplant Proc"},{"key":"BF00873965_CR6","first-page":"4241","volume":"XIX","author":"R Engemann","year":"1987","unstructured":"Engemann R, Gassel HJ, Lafrenz E, Stoffregen C, Thiede A: Transplantation tolerance after short-term administration of 15-Deoxyspergualin in orthotopic rat liver transplantation. Transplant Proc XIX:4241\u20134243, 1987","journal-title":"Transplant Proc"},{"key":"BF00873965_CR7","first-page":"1045","volume":"24","author":"DB Kaufman","year":"1992","unstructured":"Kaufman DB, Field MJ, Gruber SA, Farney AC, Stephanian E, Gores PF, Sutherland DER: Extended functional survival of murine islet allografts with 15-deoxyspergualin. Transplant Proc 24:1045\u20131047, 1992","journal-title":"Transplant Proc"},{"key":"BF00873965_CR8","first-page":"714","volume":"24","author":"HC Flores","year":"1992","unstructured":"Flores HC, Leventhal JR, Gruber SA, Figueroa J, Platt JL, Manivel C, Bach FH, Matas AJ, Bolman RM III: Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model. Transplant Proc 24:714, 1992","journal-title":"Transplant Proc"},{"key":"BF00873965_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7164\/antibiotics.43.213","volume":"43","author":"H Fujii","year":"1990","unstructured":"Fujii H, Takada T, Nemoto K, Yamashita T, Abe F, Fujii A, Takeuchi T: Deoxyspergualin directly suppresses antibody formationin vivo andin vitro. J Antibiot 43:213\u2013219, 1990","journal-title":"J Antibiot"},{"key":"BF00873965_CR10","first-page":"710","volume":"24","author":"G Gannedahl","year":"1992","unstructured":"Gannedahl G, Karlsson-Parra A, T\u00f6tterman TH, Tufveson G: 15-Deoxyspergualin and mouse to rat heart retransplantation. Transplant Proc 24:710\u2013711, 1992","journal-title":"Transplant Proc"},{"key":"BF00873965_CR11","first-page":"7750","volume":"50","author":"LH Pai","year":"1990","unstructured":"Pai LH, Fitzgerald DJ, Tepper M, Schacter B, Spitainy G, Pastan I: Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing pseudomonas exotoxin by 15-deoxyspergualin in mice. Cancer Res 50:7750\u20137743, 1990","journal-title":"Cancer Res"},{"key":"BF00873965_CR12","first-page":"1638","volume":"24","author":"S Suzuki","year":"1992","unstructured":"Suzuki S, Nishimori H, Hayashi R, Quinonez D, Amemiya H: Prolonged survival of cardiac allografts and xenografts in rat-to-rat and hamster-to-rat transplantation by treatment with deoxyspergualin. Transplant Proc 24:1638\u20131639, 1992","journal-title":"Transplant Proc"},{"key":"BF00873965_CR13","first-page":"328","volume":"23","author":"M Tepper","year":"1991","unstructured":"Tepper M, Petty B, Bursuker I, Pasternak R, Schacter BZ: Inhibition of antibody production by immunosuppressive agent, deoxyspergualin. Transplant Proc 23:328\u2013331, 1991","journal-title":"Transplant Proc"},{"key":"BF00873965_CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00007890-199002000-00022","volume":"49","author":"H Amemiya","year":"1990","unstructured":"Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibasi M, Omoto R, Koyama I, Dohi K, Fukuda Y, Fukao K: A novel rescue drug, 15-deoxyspergualin: first clinical trials for recurrent graft rejection in renal recipients. Transplantation 49:337\u2013343, 1990","journal-title":"Transplantation"},{"key":"BF00873965_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0140-6736(93)92484-B","volume":"341","author":"PF Gores","year":"1993","unstructured":"Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DER: Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341:19\u201321, 1993","journal-title":"Lancet"},{"key":"BF00873965_CR16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0140-6736(90)93419-P","volume":"336","author":"CG Groth","year":"1990","unstructured":"Groth CG, Ohlman S, Ericzon BG, Barkholt L, Reinholt FP: Deoxyspergualin for liver graft rejection. Lancet 336:626, 1990","journal-title":"Lancet"},{"key":"BF00873965_CR17","first-page":"175","volume":"11","author":"H Amemiya","year":"1991","unstructured":"Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama F, Orita K, Takagi H: Multicentre clinical trial of antirejection pulse therapy with deoxyspergualin in kidney transplant patients. Int J Clin Pharmacol Res 11:175\u2013182, 1991","journal-title":"Int J Clin Pharmacol Res"},{"key":"BF00873965_CR18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0192-0561(87)90123-8","volume":"9","author":"G Dickneite","year":"1987","unstructured":"Dickneite G, Schorlemmer HU, Sedlacek HH: Decrease of mononuclear phagocyte cell functions and prolongation of graft survival in experimental transplantation by (\u00b1)-15-deoxyspergualin. Int J Immunopharmacol 9:559\u2013565, 1987","journal-title":"Int J Immunopharmacol"},{"key":"BF00873965_CR19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000186775","volume":"60","author":"M Okubo","year":"1992","unstructured":"Okubo M, Amemiya K, Tamura K, Inoue K, Kamata K, Masaki Y: Effect of 15-deoxyspergualin on lupus nephropathy in New Zealand black\/white Fl mice. III. Dose-response effect. Nephron 60:336\u2013341, 1992","journal-title":"Nephron"},{"key":"BF00873965_CR20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/0006-2952(92)90517-M","volume":"43","author":"M Hagihara","year":"1992","unstructured":"Hagihara M, Sekiguchi K, Fujiwara M, Aoyagi T, Takeuchi T, Nagatsu T: Effects of deoxyspergualin on dipeptidyl peptidase-II and -IV in the spleen of BXSB mice andMRL\/lpr mice during the development of the lupus erythematosus-like syndrome. Biochem Pharmacol 43:1380\u20131383, 1992","journal-title":"Biochem Pharmacol"},{"key":"BF00873965_CR21","first-page":"9","volume":"1","author":"HU Schorlemmer","year":"1989","unstructured":"Schorlemmer HU, Bartlett RR, Schleyerbach R, Dickneite G, Seller FR: Immunosuppressive therapy of experimental autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus by 15-deoxyspergualin. Int J Immunotherapy 1:9\u201320, 1989","journal-title":"Int J Immunotherapy"},{"key":"BF00873965_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01993264","volume":"34","author":"HU Schorlemmer","year":"1991","unstructured":"Schorlemmer HU, Bartlett RR, Seller FR: 15-Deoxyspergualin (15-DSG) has a curative effect on the development of SLE-like autoimmune disease in MRL\/1 mice. Agents Actions 34:151\u2013155, 1991","journal-title":"Agents Actions"},{"key":"BF00873965_CR23","first-page":"461","volume":"XVII","author":"HU Schorlemmer","year":"1991","unstructured":"Schorlemmer HU, Seller FR: Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS). Drugs Exptl Clin Res XVII:461\u2013469, 1991","journal-title":"Drugs Exptl Clin Res"},{"key":"BF00873965_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/08916939008998430","volume":"8","author":"M Mochizuki","year":"1990","unstructured":"Mochizuki M, Kawashima H: Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. Autoimmunity 8:37\u201341, 1990","journal-title":"Autoimmunity"},{"key":"BF00873965_CR25","first-page":"1323","volume":"44","author":"Y Takeda","year":"1991","unstructured":"Takeda Y, Kaneko T, Matsuzawa A: Spergualin treatment-dependent delayed relapse of mouse T cell leukemia (DL812) after chemotherapy. Jpn J Antibiot 44:1323\u20131328, 1991","journal-title":"Jpn J Antibiot"},{"key":"BF00873965_CR26","first-page":"917","volume":"44","author":"K Nishikawa","year":"1991","unstructured":"Nishikawa K, Shibasaki C, Takahashi K, Takeuchi T: Treatment schedule dependency of antitumor effect of deoxyspergualin. Jpn J Antibiot 44:917\u2013925, 1991","journal-title":"Jpn J Antibiot"},{"key":"BF00873965_CR27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.7164\/antibiotics.44.1101","volume":"44","author":"K Nishikawa","year":"1991","unstructured":"Nishikawa K, Shibasaki C, Hiratsuka M, Arakawa M, Takahashi K, Takeuchi T: Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents. J Antibiot 44:1101\u20131109, 1991","journal-title":"J Antibiot"},{"key":"BF00873965_CR28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7164\/antibiotics.44.1237","volume":"44","author":"K Nishikawa","year":"1991","unstructured":"Nishikawa K, Shibasaki C, Uchida T, Takahashi K, Takeuchi T: The nature ofin vivo cell-killing of deoxyspergualin, and its implication in combination with other antitumor agents. J Antibiot 44:1237\u20131246, 1991","journal-title":"J Antibiot"},{"key":"BF00873965_CR29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1349-7006.1991.tb01758.x","volume":"82","author":"M Hiratsuka","year":"1991","unstructured":"Hiratsuka M, Kuramochi H, Takahashi K, Takeuchi T, Oshimura M: Cytostatic effect of deoxyspergualin on a murine leukemia cell line L1210. Jpn J Cancer Res 82:1065\u20131068, 1991","journal-title":"Jpn J Cancer Res"},{"key":"BF00873965_CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00001813-199206000-00014","volume":"3","author":"T Oikawa","year":"1992","unstructured":"Oikawa T, Hasegawa M, Morita I, Murota S, Ashino H, Shimamura M, Kiue A, Hamanaka R, Kuwano M, Ishizuka M: Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells. Anti-Cancer Drugs 3:293\u2013299, 1992","journal-title":"Anti-Cancer Drugs"},{"key":"BF00873965_CR31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1349-7006.1992.tb01981.x","volume":"83","author":"K Nemoto","year":"1992","unstructured":"Nemoto K, Sugawara Y, Ogino M, Mae T, Abe F, Takeuchi T: Myeloprotective activity of deoxysper-gualin: Influence on splenic colony-forming cell injury and antitumor activity of mitomycin C in mice. Jpn J Cancer Res 83:789\u2013793, 1992","journal-title":"Jpn J Cancer Res"},{"key":"BF00873965_CR32","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO;2-F","volume":"39","author":"JL Hayward","year":"1977","unstructured":"Hayward JL, Carbone PP, Heuwson JC: Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer 39:1289\u20131294, 1977","journal-title":"Cancer"},{"key":"BF00873965_CR33","first-page":"1935","volume-title":"Harrison's Principles of Internal Medicine","author":"JP Kn\u00f6chel","year":"1993","unstructured":"Kn\u00f6chel JP: Disorders of magnesium metabolism, in Wilson JD, Isselbacher KJ, Petersdorf RGet al. (eds.), Harrison's Principles of Internal Medicine. (12th ed.). New York, McGraw Hill, 1993, pp 1935\u20131938","edition":"12th ed."},{"key":"BF00873965_CR34","doi-asserted-by":"crossref","unstructured":"Dhingra K, Fritsche H, Murray JL, Lobuglio AF,Khazaeli MB, Kelley S, Tepper M, Greene D, Booser D, Buzdar A, Raber M, Gutierrez L, Hortobagyi G: Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: A phase I study, in Ceriani RL (ed). Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment. Plenum Publishing Corp., 1994, pp 193\u2013202","DOI":"10.1007\/978-1-4615-2443-4_18"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00873965\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T03:50:30Z","timestamp":1678506630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00873965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF00873965"],"URL":"https:\/\/doi.org\/10.1007\/bf00873965","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}